Chemoinformaics analysis of 2,6-Di-tert-butylphenol
| Molecular Weight | 206.329 | nRot | 0 |
| Heavy Atom Molecular Weight | 184.153 | nRig | 6 |
| Exact Molecular Weight | 206.167 | nRing | 1 |
| Solubility: LogS | -4.714 | nHRing | 0 |
| Solubility: LogP | 4.585 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 1 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 6 |
| nHA | 1 | APOL | 38.8514 |
| nHD | 1 | BPOL | 22.0706 |
| QED | 0.68 |
| Synth | 2.056 |
| Natural Product Likeliness | -0.028 |
| NR-PPAR-gamma | 0.833 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.887 |
| Pgp-sub | 0.005 |
| HIA | 0.625 |
| CACO-2 | -4.921 |
| MDCK | 0.0000151 |
| BBB | 0.294 |
| PPB | 0.991973 |
| VDSS | 5.069 |
| FU | 0.0393428 |
| CYP1A2-inh | 0.871 |
| CYP1A2-sub | 0.917 |
| CYP2c19-inh | 0.6 |
| CYP2c19-sub | 0.837 |
| CYP2c9-inh | 0.532 |
| CYP2c9-sub | 0.863 |
| CYP2d6-inh | 0.791 |
| CYP2d6-sub | 0.813 |
| CYP3a4-inh | 0.417 |
| CYP3a4-sub | 0.62 |
| CL | 5.683 |
| T12 | 0.271 |
| hERG | 0.007 |
| Ames | 0.005 |
| ROA | 0.168 |
| SkinSen | 0.754 |
| Carcinogencity | 0.037 |
| EI | 0.978 |
| Respiratory | 0.659 |
| NR-Aromatase | 0.032 |
| Antiviral | Yes |
| Prediction | 0.777731 |